nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CMA1—tunica intima—abdominal aortic aneurysm	0.111	0.3	CbGeAlD
Boceprevir—CTSK—leg—abdominal aortic aneurysm	0.0446	0.121	CbGeAlD
Boceprevir—CTSK—hindlimb—abdominal aortic aneurysm	0.0398	0.108	CbGeAlD
Boceprevir—CMA1—artery—abdominal aortic aneurysm	0.0379	0.103	CbGeAlD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGTR1—abdominal aortic aneurysm	0.0204	0.0324	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.02	0.0318	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0186	0.0296	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP14—abdominal aortic aneurysm	0.0175	0.0277	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0166	0.0263	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—LOX—abdominal aortic aneurysm	0.0154	0.0245	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—LOX—abdominal aortic aneurysm	0.0154	0.0245	CbGpPWpGaD
Boceprevir—CMA1—connective tissue—abdominal aortic aneurysm	0.0151	0.041	CbGeAlD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—AGT—abdominal aortic aneurysm	0.0151	0.0239	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP14—abdominal aortic aneurysm	0.0145	0.023	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—AGT—abdominal aortic aneurysm	0.0144	0.0228	CbGpPWpGaD
Boceprevir—CTSV—kidney—abdominal aortic aneurysm	0.0135	0.0365	CbGeAlD
Boceprevir—CTSL—connective tissue—abdominal aortic aneurysm	0.0129	0.035	CbGeAlD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.0118	0.0187	CbGpPWpGaD
Boceprevir—CTSL—kidney—abdominal aortic aneurysm	0.011	0.0298	CbGeAlD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.011	0.0174	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—LOX—abdominal aortic aneurysm	0.0105	0.0167	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—LOX—abdominal aortic aneurysm	0.0105	0.0167	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—LOX—abdominal aortic aneurysm	0.0105	0.0167	CbGpPWpGaD
Boceprevir—CTSV—spinal cord—abdominal aortic aneurysm	0.0105	0.0284	CbGeAlD
Boceprevir—CTSL—Collagen degradation—MMP3—abdominal aortic aneurysm	0.0103	0.0163	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00979	0.0155	CbGpPWpGaD
Boceprevir—CTSK—connective tissue—abdominal aortic aneurysm	0.00975	0.0264	CbGeAlD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00884	0.014	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00884	0.014	CbGpPWpGaD
Boceprevir—CTSL—spinal cord—abdominal aortic aneurysm	0.00858	0.0232	CbGeAlD
Boceprevir—CTSS—connective tissue—abdominal aortic aneurysm	0.00855	0.0231	CbGeAlD
Boceprevir—CTSK—Collagen degradation—MMP3—abdominal aortic aneurysm	0.00853	0.0135	CbGpPWpGaD
Boceprevir—CTSK—kidney—abdominal aortic aneurysm	0.0083	0.0225	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00822	0.013	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.00801	0.0127	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.00801	0.0127	CbGpPWpGaD
Boceprevir—CTSL—Antigen processing-Cross presentation—NCF1—abdominal aortic aneurysm	0.00793	0.0126	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—NCF1—abdominal aortic aneurysm	0.00793	0.0126	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00733	0.0116	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00731	0.0116	CbGpPWpGaD
Boceprevir—CTSS—kidney—abdominal aortic aneurysm	0.00728	0.0197	CbGeAlD
Boceprevir—CTSS—Collagen formation—LOX—abdominal aortic aneurysm	0.00717	0.0114	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.0068	0.0108	CbGpPWpGaD
Boceprevir—CTSK—spinal cord—abdominal aortic aneurysm	0.00647	0.0175	CbGeAlD
Boceprevir—CTSL—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00637	0.0101	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00607	0.00962	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00607	0.00962	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00606	0.00961	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00604	0.00957	CbGpPWpGaD
Boceprevir—CTSS—spinal cord—abdominal aortic aneurysm	0.00567	0.0153	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00564	0.00894	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00549	0.00871	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.00547	0.00867	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP3—abdominal aortic aneurysm	0.00546	0.00866	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP3—abdominal aortic aneurysm	0.00546	0.00866	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—NCF1—abdominal aortic aneurysm	0.00541	0.00858	CbGpPWpGaD
Boceprevir—CYP3A5—blood plasma—abdominal aortic aneurysm	0.00533	0.0144	CbGeAlD
Boceprevir—CTSK—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00528	0.00837	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00521	0.00827	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00521	0.00827	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00511	0.0081	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00503	0.00797	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00485	0.00769	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP9—abdominal aortic aneurysm	0.00479	0.00759	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00455	0.00722	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00432	0.00685	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00421	0.00667	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00421	0.00667	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00414	0.00656	CbGpPWpGaD
Boceprevir—CYP3A4—blood plasma—abdominal aortic aneurysm	0.004	0.0108	CbGeAlD
Boceprevir—CMA1—Peptide hormone metabolism—AGT—abdominal aortic aneurysm	0.00397	0.00629	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP9—abdominal aortic aneurysm	0.00397	0.00629	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00391	0.0062	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP9—abdominal aortic aneurysm	0.00373	0.00591	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP9—abdominal aortic aneurysm	0.00373	0.00591	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP3—abdominal aortic aneurysm	0.00373	0.00591	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00371	0.00588	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00371	0.00588	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00356	0.00564	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00348	0.00553	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00345	0.00546	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00322	0.00511	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00322	0.00511	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—NCF1—abdominal aortic aneurysm	0.00317	0.00502	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—NCF1—abdominal aortic aneurysm	0.00317	0.00502	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—MMP9—abdominal aortic aneurysm	0.00316	0.005	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00307	0.00487	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.003	0.00475	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00292	0.00463	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00287	0.00455	CbGpPWpGaD
Boceprevir—ABCB1—blood plasma—abdominal aortic aneurysm	0.00283	0.00767	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00267	0.00424	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—abdominal aortic aneurysm	0.00254	0.00403	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP9—abdominal aortic aneurysm	0.00254	0.00403	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP9—abdominal aortic aneurysm	0.00254	0.00403	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00253	0.00401	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00242	0.00384	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00242	0.00384	CbGpPWpGaD
Boceprevir—CYP3A5—kidney—abdominal aortic aneurysm	0.00242	0.00654	CbGeAlD
Boceprevir—CTSL—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.0023	0.00364	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.0023	0.00364	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00225	0.00357	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.0022	0.00349	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00218	0.00346	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00218	0.00346	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—NCF1—abdominal aortic aneurysm	0.00216	0.00343	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00203	0.00322	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00201	0.00318	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.0019	0.00302	CbGpPWpGaD
Boceprevir—CYP3A4—kidney—abdominal aortic aneurysm	0.00181	0.00491	CbGeAlD
Boceprevir—CTSK—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00181	0.00287	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP9—abdominal aortic aneurysm	0.00173	0.00275	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.00166	0.00263	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.00166	0.00263	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00165	0.00262	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.00157	0.00249	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.00157	0.00249	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.00157	0.00249	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.00156	0.00247	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00149	0.00236	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SELL—abdominal aortic aneurysm	0.00139	0.00221	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SELL—abdominal aortic aneurysm	0.00139	0.00221	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.00138	0.00218	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.00135	0.00214	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.00135	0.00214	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.00133	0.0021	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.00133	0.0021	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.0013	0.00206	CbGpPWpGaD
Boceprevir—ABCB1—kidney—abdominal aortic aneurysm	0.00128	0.00347	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.00126	0.00199	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.00123	0.00195	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AAAS—abdominal aortic aneurysm	0.00116	0.00185	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AAAS—abdominal aortic aneurysm	0.00116	0.00185	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SELL—abdominal aortic aneurysm	0.00115	0.00183	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.00113	0.0018	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.00112	0.00178	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.0011	0.00174	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.00107	0.0017	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.00102	0.00161	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.00102	0.00161	CbGpPWpGaD
Boceprevir—ABCB1—spinal cord—abdominal aortic aneurysm	0.000999	0.00271	CbGeAlD
Boceprevir—CTSK—Immune System—AAAS—abdominal aortic aneurysm	0.000965	0.00153	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SELL—abdominal aortic aneurysm	0.000951	0.00151	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NCF1—abdominal aortic aneurysm	0.000951	0.00151	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NCF1—abdominal aortic aneurysm	0.000951	0.00151	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000944	0.0015	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000922	0.00146	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000905	0.00143	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000842	0.00133	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000806	0.00128	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AAAS—abdominal aortic aneurysm	0.000795	0.00126	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NCF1—abdominal aortic aneurysm	0.000788	0.00125	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000754	0.0012	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.000749	0.00119	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.000724	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000693	0.0011	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NCF1—abdominal aortic aneurysm	0.000649	0.00103	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.000617	0.000979	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000611	0.000969	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000587	0.000931	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000572	0.000906	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000538	0.000852	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000538	0.000852	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.000537	0.000851	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000516	0.000819	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000516	0.000819	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000459	0.000728	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000452	0.000717	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000445	0.000706	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000428	0.000678	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000409	0.000649	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000367	0.000582	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000352	0.000559	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000323	0.000512	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000316	0.000502	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKB1—abdominal aortic aneurysm	0.000313	0.000497	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NFKB1—abdominal aortic aneurysm	0.000313	0.000497	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000266	0.000422	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKB1—abdominal aortic aneurysm	0.000259	0.000411	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000248	0.000394	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000216	0.000343	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NFKB1—abdominal aortic aneurysm	0.000214	0.000339	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00019	0.000302	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000188	0.000298	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000169	0.000268	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000146	0.000232	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.000134	0.000213	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.000117	0.000186	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000101	0.000161	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	8.84e-05	0.00014	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	6.24e-05	9.89e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	6.19e-05	9.82e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	6.07e-05	9.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	5.45e-05	8.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	4.67e-05	7.41e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	4.58e-05	7.26e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	4.16e-05	6.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	3.14e-05	4.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.88e-05	4.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	2.82e-05	4.47e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.93e-05	3.07e-05	CbGpPWpGaD
